Trichomonas Vaginitis

02/01/1961 - "[Effective treatment of Trichomonas vaginitis by metronidazole]."
07/01/2023 - "The current treatment for human trichomoniasis is based on 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole, known as Metronidazole (MTZ). "
03/01/2016 - "Metronidazole is the drug of choice recommended for the treatment of human trichomoniasis but it can lead to drug resistance and many other adverse effects. "
03/01/1996 - "Our purpose was to develop and test an incremental dosing protocol for women with adverse reaction to metronidazole and severe symptomatic Trichomonas vaginitis. "
06/01/1993 - "Trichomonas vaginitis usually responds to oral metronidazole, and treatment of sexual partners is recommended. "

03/01/1978 - "No significant differences were seen in the success rate between the three drug regimens and the preliminary conclusions of the trial are that ornidazole is safe and effective in the treatment of trichomonas vaginitis in Korean women with an oral dose of 1.0 gm, 1.0 gm plus 0.5 gm intravaginally or 2.0 gm given in a single day."
03/01/1978 - "A total of 107 cases of trichomonas vaginitis were treated with different regimens of ornidazole. "
03/01/1978 - "Single-day treatment of trichomonas vaginitis with low dose of ornidazole."
12/01/2020 - "The traditional treatment method, ornidazole suppository, showed an effective rate of 79.5% for bacterial vaginitis and 88.9% for trichomonas vaginitis. "
12/01/2020 - "Bacterial vaginosis and trichomonas vaginitis were treated with nano-Ag/TiO₂ composite antibacterial agent (composite treatment group) and ornidazole suppository (traditional treatment group). "

01/01/1985 - "[Specific antibodies in women treated for Trichomonas vaginitis]."
03/01/1958 - "[Demonstration of local antibodies in trichomonas vaginitis]."
03/01/1998 - "For sexually transmitted diseases, bovine trichomoniasis is a useful model because it resembles human trichomoniasis to some extent, and antibodies play an important role in protection against these extracellular parasites. "
06/01/1987 - "[Detection of IgG antibodies with immunofluorescent antibody technique in human trichomoniasis]"
03/01/1990 - "[Detection of IgG and IgM antibodies with ELISA technique in human trichomoniasis]."

07/01/2001 - "This improved method may be suitable for routine DNA extraction for the diagnosis of cattle and even human trichomoniasis by PCR."
01/01/2010 - "Potential self-diagnoses were "bacterial infection" (bacterial vaginosis [BV] and/or trichomonas vaginitis [TV]), "yeast infection" (candida vaginitis [CV]), "no infection/normal," or "unclear." The Affirm VPIII laboratory reference standard was used to detect clinically significant amounts of vaginal fluid DNA for organisms associated with BV, TV, and CV. "
04/01/2001 - "For Trichomonas vaginitis (n=55), HIV-1 RNA decreased from 3.67 to 3.05 log(10) copies/swab (P<.001), but the prevalence of HIV-1 DNA remained unchanged (22%-25%; OR, 0.8; 95% CI, 0.3-2.2). "

08/01/1951 - "Treatment of trichomonas vaginitis; use of an improved vaginal cream."
01/01/1970 - "[Clinical study on the effectiveness of vaginal cream with metronidazole base in treatment of trichomonas vaginitis]."

05/01/1984 - "In view of the high cure rates of Trichomonas vaginitis after vaccination with the immunotherapeutic drug Solco Trichovac Gynatren, the therapeutic efficacy of this regimen in nonspecific vaginitis was investigated. "
11/01/1986 - "[Results of treating Trichomonas vaginitis with Solco-Trichovac vaccine]."

01/01/1975 - " This study presents the results of the use of a single dose treatment of Trichomonas vaginitis with 2.0 gm Tinidazole. "
11/01/2014 - "Oral tinidazole for refractory Trichomonas vaginitis."
01/01/1979 - "[Various parameters of the peripheral blood in Trichomonas vaginitis treated with tinidazole (Fasigyn)]."
01/01/1977 - "[Effectiveness of tinidazole in the treatment of trichomonas vaginitis in girls]."
01/01/1977 - "[Effectiveness and side effects of a single oral dose of Fasigyn in the treatment of trichomonas vaginitis]."

04/01/1964 - "[CLINICAL EXPERIENCE WITH A ORAL TABLET OF NEW AGENT PIPERANITROLE FOR TRICHOMONAS VAGINITIS]."
01/01/2023 - "Retracted: Clinical Effect of Metronidazole Vaginal Effervescent Tablet Combined with Flavescentis Sophora Suppository in the Treatment of Trichomonas Vaginitis."
01/01/2022 - "Clinical Effect of Metronidazole Vaginal Effervescent Tablet Combined with Flavescentis Sophora Suppository in the Treatment of Trichomonas Vaginitis."
01/01/2022 - "For the treatment of trichomonas vaginitis, a combination therapy of metronidazole vaginal effervescent tablet combined with Flavescentis Sophora suppository is proposed. "
01/01/2022 - "The aim of this study was to explore the clinical effects of metronidazole vaginal effervescent tablets combined with Kushen suppository in the treatment of Trichomonas vaginitis. "

12/01/2020 - "This study investigated the effect of nano-Ag/TiO₂ composite antibacterial agent on bacterial vaginosis and trichomonas vaginitis. "
12/01/2020 - "Therefore, the nano-Ag/TiO₂ composite antibacterial agent was determined to be an effective treatment method for bacterial vaginosis and trichomonas vaginitis."
12/01/2020 - "The effective rate of the nano-Ag/TiO₂ composite antibacterial agent was 97.0% for bacterial vaginosis and 94.4% for trichomonas vaginitis. "
04/01/2005 - "Pre-MEDLINE and MEDLINE (1966-2003), EMBASE (1980-2003), and the Cochrane Library were searched using the keywords "bacterial vaginosis", "Trichomonas", "Trichomonas vaginalis", "Trichomonas vaginitis", "Trichomonas infections", "pregnancy", "pregnant", "antibiotics", and "antibiotic prophylaxis". "
12/01/2021 - "Nitroaromatic antibiotics show activity against anaerobic bacteria and parasites, finding use in the treatment of Heliobacter pylori infections, tuberculosis, trichomoniasis, human African trypanosomiasis, Chagas disease and leishmaniasis. "

01/01/2022 - "The aim of this study was to explore the clinical effects of metronidazole vaginal effervescent tablets combined with Kushen suppository in the treatment of Trichomonas vaginitis. "
01/01/2023 - "Retracted: The Clinical Effects of Metronidazole Vaginal Effervescent Tablets Combined with Kushen Suppository in the Treatment of Trichomonas Vaginitis."
01/01/2022 - "Metronidazole vaginal effervescent tablets combined with Kushen suppository can effectively improve the clinical symptoms of patients with trichomonas vaginitis, abate patient's inflammatory reaction, and raise their quality of life, which is worthy of promotion."
01/01/2022 - "The Clinical Effects of Metronidazole Vaginal Effervescent Tablets Combined with Kushen Suppository in the Treatment of Trichomonas Vaginitis."

02/27/1959 - "[A study on therapy of trichomonas vaginitis]."
07/01/1978 - "[New trends in the therapy of trichomonas vaginitis]."
01/01/1977 - "[Secondary fluorescence in the diagnosis of trichomonas vaginitis and in the control of the effectiveness of antitrichomonal therapy]."
04/01/1958 - "[Hopes & despairs of Trichomonas vaginitis therapy]."
03/01/1958 - "[Preliminary findings on the effectiveness of a new preparation for local use in therapy of microbial, mycotic and trichomonas vaginitis]."

01/01/2022 - "The patients are followed up for 6 months after treatment in order to observe the recurrence of trichomonas vaginitis in both groups. "
12/25/1967 - "[Trichomonas vaginitis, its treatment and colposcopic findings before and after treatment]."
04/01/2001 - "To assess the effect of treatment of vaginal infections on vaginal shedding of cell-free human immunodeficiency virus type 1 (HIV-1) and HIV-1-infected cells, HIV-1-seropositive women were examined before and after treatment of Candida vulvovaginitis, Trichomonas vaginitis, and bacterial vaginosis. "

04/01/2005 - "Pre-MEDLINE and MEDLINE (1966-2003), EMBASE (1980-2003), and the Cochrane Library were searched using the keywords "bacterial vaginosis", "Trichomonas", "Trichomonas vaginalis", "Trichomonas vaginitis", "Trichomonas infections", "pregnancy", "pregnant", "antibiotics", and "antibiotic prophylaxis". "

06/01/1957 - "Treatment of trichomonas vaginitis with terramycin vaginal pessaries."

01/01/1977 - "[Use of intrauterine devices complicated by trichomonas vaginitis]."